Related Experiment Video
Updated: Sep 17, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Genome-wide pQTL mapping in human skin identifies specific genetic regulators and mechanistic links to skin disorders
Yuanqiang Sun1,2, Wenchao Li1,2, Zhenzhen Wang1,2
1Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Abstract:
Understanding how genetic variation shapes tissue-specific protein expression is fundamental for uncovering disease mechanisms and therapeutic targets. However, the proteomic landscape and its underlying genetic regulation in skin, the largest human organ, remain largely uncharted. Here, we present a population-level skin proteomic dataset, quantifying 5,774 proteins across 248 individuals and revealing substantial inter-individual variation shaped by genetic and non-genetic factors. Genome-wide pQTL analysis identifies 1,765 significant variant-protein associations involving 36 proteins, with 62% unsupported by skin eQTL and 33% not replicated in non-skin pQTL. Integrating skin pQTL with ancestry-matched leprosy GWAS identifies 11 risk proteins through proteome-wide association study (PWAS), with four showing causal evidence from colocalization or Mendelian randomization analyses. Further integration with European GWASs for atopic dermatitis and psoriasis identifies known and novel disease-related proteins, demonstrating the cross-ancestry utility of skin pQTL. Together, this work establishes a valuable resource for skin proteogenomics and disease-gene discovery in dermatology.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Pleiotropy